1. Home
  2. CRDL vs ACU Comparison

CRDL vs ACU Comparison

Compare CRDL & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDL
  • ACU
  • Stock Information
  • Founded
  • CRDL 2017
  • ACU 1867
  • Country
  • CRDL Canada
  • ACU United States
  • Employees
  • CRDL N/A
  • ACU N/A
  • Industry
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • ACU Industrial Machinery/Components
  • Sector
  • CRDL Health Care
  • ACU Consumer Discretionary
  • Exchange
  • CRDL Nasdaq
  • ACU Nasdaq
  • Market Cap
  • CRDL 142.5M
  • ACU 155.9M
  • IPO Year
  • CRDL N/A
  • ACU N/A
  • Fundamental
  • Price
  • CRDL $1.58
  • ACU $41.66
  • Analyst Decision
  • CRDL Strong Buy
  • ACU
  • Analyst Count
  • CRDL 3
  • ACU 0
  • Target Price
  • CRDL $9.00
  • ACU N/A
  • AVG Volume (30 Days)
  • CRDL 421.9K
  • ACU 17.5K
  • Earning Date
  • CRDL 11-14-2024
  • ACU 10-18-2024
  • Dividend Yield
  • CRDL N/A
  • ACU 1.45%
  • EPS Growth
  • CRDL N/A
  • ACU 188.89
  • EPS
  • CRDL N/A
  • ACU 4.84
  • Revenue
  • CRDL N/A
  • ACU $190,488,947.00
  • Revenue This Year
  • CRDL N/A
  • ACU $5.34
  • Revenue Next Year
  • CRDL N/A
  • ACU $2.96
  • P/E Ratio
  • CRDL N/A
  • ACU $8.55
  • Revenue Growth
  • CRDL N/A
  • ACU N/A
  • 52 Week Low
  • CRDL $0.79
  • ACU $32.85
  • 52 Week High
  • CRDL $3.12
  • ACU $50.99
  • Technical
  • Relative Strength Index (RSI)
  • CRDL 30.69
  • ACU 51.09
  • Support Level
  • CRDL $1.83
  • ACU $40.51
  • Resistance Level
  • CRDL $1.92
  • ACU $42.70
  • Average True Range (ATR)
  • CRDL 0.15
  • ACU 1.06
  • MACD
  • CRDL -0.04
  • ACU 0.08
  • Stochastic Oscillator
  • CRDL 12.00
  • ACU 74.38

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

Share on Social Networks: